Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
2.040
+0.005 (0.25%)
Jul 25, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Year Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 NaN - NaN
Research and Development of Pharmaceutical Products
61.64M
Log In
Log In
Log In
Log In
Upgrade
Research and Development of Pharmaceutical Products Growth
6.88%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Year Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 NaN - NaN
France
61.64M
Log In
Log In
Log In
Log In
Upgrade
France Growth
6.88%
Log In
Log In
Log In
Log In
Upgrade